Alpha 2.0
Login Register
» Authors » Burcu Uzunoglu

Burcu Uzunoglu

Explore the profile of Burcu Uzunoglu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 8
Followers 0
Related Specialties
Pulmonary Medicine
Pediatrics
Top 10 Co-Authors
Gamze Tastan
Yasemin Gokdemir
Bulent Karadag
Ela Erdem Eralp
Fazilet Karakoc
Almala Pinar Ergenekon
Seyda Karabulut
Merve Selcuk Balci
Muruvvet Yanaz
Neval Metin Cakar
Published In
Pediatr Pulmonol
J Cyst Fibros
Respiration
Affiliations
Soon will be listed here.
Recent Articles
1.
Elexacaftor/Tezacaftor/Ivacaftor Treatment Accessibility and Mental Health: Reducing Anxiety in People With Cystic Fibrosis
Uzunoglu B, Selcuk Balci M, Kalyoncu M, Karabulut S, Metin Cakar N, Yildiz C, et al.
Pediatr Pulmonol . 2025 Mar; 60(3):e71037. PMID: 40062574
Background: Although modulator therapies have proven effective in cystic fibrosis (CF) access is limited due to reimbursement issues in Turkey. We aimed to examine anxiety and depression levels of people...
2.
Implementation of Cystic Fibrosis Responsibility, Independence, Self-Care, Education Program Enhances Cystic Fibrosis Knowledge in Limited Resource Country: Results From a Randomized Controlled Trial
Selcuk Balci M, Gokdemir Y, Erdem Eralp E, Ergenekon A, Yilmaz Yegit C, Yanaz M, et al.
Pediatr Pulmonol . 2025 Feb; 60(2):e27506. PMID: 39898696
Background: CF R.I.S.E is a program that helps people with Cystic Fibrosis (pwCF) transition from pediatric to adult care. In 2022, we adapted it to CF S.O.B.E in Turkish during...
3.
Associations between income level and health outcomes in people with cystic fibrosis in Turkey
Metin Cakar N, Karabulut S, Yuksel Kalyoncu M, Selcuk Balci M, Yildiz C, Kocaman D, et al.
J Cyst Fibros . 2024 Nov; PMID: 39516142
Background: Our study aimed to identify the social domains that pose the greatest barriers to managing and supporting pwCF, particularly in relation to income levels. Methods: To identify associations between...
4.
The Association between Aminoglycoside Exposure and Ototoxicity in Children with Cystic Fibrosis
Yilmaz Yegit C, Ergenekon P, Yanaz M, Ozturk Akar N, Toktas Yavuz F, Molla Kafi H, et al.
Respiration . 2024 Sep; 104(1):48-57. PMID: 39299224
Introduction: Pulmonary exacerbations increase the requirement of aminoglycoside (AG) antibiotics in people with cystic fibrosis (pwCF). Several studies have shown that AGs have a cumulative effect on ototoxicity. We aimed...
5.
Exploring Turkey's mosaic of novel variants and complex alleles in cystic fibrosis genetics
Yildiz C, Selcuk Balci M, Karabulut S, Baser Z, Kalyoncu M, Metin Cakar N, et al.
Pediatr Pulmonol . 2024 Sep; 59(12):3540-3549. PMID: 39291770
Backgrounds: Genetic variants in CF transmembrane conductance regulator (CFTR) gene causes cystic fibrosis (CF), a prevalent autosomal recessive disorder. More than 2000 variants in CFTR have been described as disease...
6.
Assessment of patients' baseline cystic fibrosis knowledge levels following translation and adaptation of the CF R.I.S.E translation program into Turkish
Selcuk Balci M, Gokdemir Y, Erdem Eralp E, Ergenekon A, Yilmaz Yegit C, Yanaz M, et al.
Pediatr Pulmonol . 2024 Sep; 59(12):3483-3490. PMID: 39221873
Background: Cystic fibrosis (CF) patients have a limited life expectancy, but significant medical advances now highlight the need for successful transition programs from pediatric to adult care. The goal of...
7.
Beyond the 10%: Unraveling the genetic diversity in Turkish cystic fibrosis patients not eligible for CFTR modulators
Yildiz C, Selcuk Balci M, Karabulut S, Baser Z, Yuksel Kalyoncu M, Metin Cakar N, et al.
Pediatr Pulmonol . 2024 Jul; 59(12):3250-3259. PMID: 39031495
Background: Cystic fibrosis (CF) is an autosomal recessive disease caused by variants of CFTR gene. Over 2000 variants have been identified, and new drugs called CFTR modulators have been developed...
8.
Electronic home monitoring of children with cystic fibrosis to detect and treat acute pulmonary exacerbations and its effect on 1-year FEV
Yanaz M, Yilmaz Yegit C, Gulieva A, Kalyoncu M, Selcuk M, Uzunoglu B, et al.
J Cyst Fibros . 2023 Sep; 23(2):329-333. PMID: 37748990
Background: We aimed to investigate the effect of the use of electronic home spirometry in children with cystic fibrosis (CF) on 1-year FEV (% predicted, pp) change. Methods: This is...
9.
Implementation of standardized cystic fibrosis care algorithm to improve the center data-quality improvement project international collaboration
Gokdemir Y, Erdem Eralp E, Ergenekon A, Yilmaz Yegit C, Yanaz M, Mursaloglu H, et al.
J Cyst Fibros . 2023 Apr; 22(4):710-714. PMID: 37037703
Background: A collaboration between the University of Michigan (U of M) Cystic Fibrosis Center (CFC) and Marmara University (MU) CFC was initiated to improve the health status of people with...
10.
Improvements in body mass index of children with cystic fibrosis following implementation of a standardized nutritional algorithm: A quality improvement project
Gokdemir Y, Erdem Eralp E, Ergenekon A, Yilmaz Yegit C, Yanaz M, Mursaloglu H, et al.
Pediatr Pulmonol . 2023 Feb; 58(5):1463-1470. PMID: 36747482
Background: A collaboration between the University of Michigan (UM) Cystic Fibrosis Center (CFC) and Marmara University (MU) CFC was initiated in MU through conducting Quality Improvement projects (QIP). The global...